Health technology company Medopad has a successful round of funding for its project that hopes to use big data to manage chroni diseases, reports Venture Beat. 

Medopad, a U.K.-based health technology startup that uses machine learning and big data analyses to help predict and manage chronic diseases, has raised $25 million in a series B round of funding led by Leaps by Bayer, the VC arm of German pharmaceutical giant Bayer, with participation from NWS Holdings and Healthbox, among other investors.

Digital health company Savonix hopes to use big data to find a cure for Alzheimer’s, reports IEEE Spectrum. 

During the Framingham Heart Study, a long-term research study initiated in 1948 that collected health data from thousands of people, researchers discovered that high cholesterol and elevated blood pressure increase one’s risk of heart disease

Financial institutes are taking an interest in big data, reports the Financial Brand.

Futurist Mike Walsh has good news and bad news for financial services executives leading and working in the Algorithmic Age.